Quantcast
Home / Opinions / Opinion Digest / Baycol maker had no duty to provide added warnings

Baycol maker had no duty to provide added warnings

A drug manufacturer had no duty to warn of the higher incidence of “adverse events” reported by those taking the company’s anti-cholesterol drug, a Pennsylvania appeals court has ruled in an unpublished decision affirming a defense verdict.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top